{"SPADE_UN_00216": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_00216", "Peptide Name": "CRISPR-associated endoribonuclease Cas2 (Antiviral defensin)", "Source": "Frankia alni (strain ACN14a)", "Family": "Belongs to the CRISPR-associated endoribonuclease Cas2 prote", "Gene": "cas2", "Sequence": "MFVVLVYDTAAERNPNALRTCRKYLHWVQRSVFEGELSAAQYRALMTTLRDQLDLTYDSIRVYRTRSPALVETEWLGVPLGNQDSVL", "Sequence Length": 87, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q0RE94"], "Protein Existence": "Homology", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "No MICs found in DRAMP database", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Metal-binding", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C449H708N126O132S3", "Mass": 10079.38, "PI": 6.55, "Net Charge": 1, "Hydrophobicity": -0.21, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Function": "CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease (By similarity).", "Literature": [{"Title": "Genome characteristics of facultatively symbiotic Frankia sp. strains reflect host range and host plant biogeography.", "Pubmed ID": "17151343", "Reference": "Genome Res. 2007 Jan;17(1)7-15.", "Author": "Normand P, Lapierre P, Tisa LS, Gogarten JP, Alloisio N, Bagnarol E, Bassi CA, Berry AM, Bickhart DM, Choisne N, Couloux A, Cournoyer B, Cruveiller S, Daubin V, Demange N, Francino MP, Goltsman E, Huang Y, Kopp OR, Labarre L, Lapidus A, Lavire C, Marechal J, Martinez M, Mastronunzio JE, Mullin BC, Niemann J, Pujic P, Rawnsley T, Rouy Z, Schenowitz C, Sellstedt A, Tavares F, Tomkins JP, Vallenet D, Valverde C, Wall LG, Wang Y, Medigue C, B", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17151343"}], "Frequent Amino Acids": "LRV", "Absent Amino Acids": "OU", "Basic Residues": 11, "Acidic Residues": 10, "Hydrophobic Residues": 43, "Polar Residues": 52, "Positive Residues": 11, "Negative Residues": 10, "Similar Sequences": []}}}